Symrise Reports Strong Financial Performance for 2025

Symrise AG achieved a 2.8% organic sales growth in 2025, with group sales reaching €4.929 billion. The adjusted EBITDA margin rose to 21.9%, showing a 120 basis points increase year-on-year. The company reported a record Business Free Cash Flow of €780 million, with a BFCF margin of 15.8%, up by 220 basis points. Strategic decisions included a €400 million share buyback and a proposed dividend increase to €1.25 per share.

CEO Dr. Jean-Yves Parisot attributed the success to the implementation of the ONE Symrise Strategy. This resulted in €50 million in cost savings and efficiency gains, exceeding initial targets. He emphasized that investments in innovation and capacity have strengthened the company's foundation for future growth. The Taste, Nutrition & Health Segment reported a segment EBITDA of €722 million, and the Scent & Care Segment saw an EBITDA of €359 million.

Looking forward to 2026, Symrise aims for an organic sales growth of 2.0-4.0%, and an adjusted EBITDA margin between 21.5% and 22.5%. The focus remains on commercial excellence and innovation.